Delivery Order SPE2DB24D2003-SPE2DB25FXMQ7
- Not listed
- The Defense Logistics Agency awarded a $47,741.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). The delivery order, which is unclassified as a set-aside contract, is scheduled for completion by September 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract issued under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a $1,930.67 delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) under a firm fixed-price contract valued at $12,323.76. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive delivery order placed against the contractor's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.08 to AmerisourceBergen Drug Corp for KERENDIA 20 MG tablets (30-count package) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,212.34 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count units) under a firm fixed price contract type. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order fulfilled by the prime contractor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $5,211.66 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kerendia 10 mg tablets (90-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,344.93 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count package) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Kerendia 10 mg tablets (30-count units). This firm fixed-price delivery order, valued at $15,382.34, was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) with a ceiling value of $2,330.76. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 4, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) on September 8, 2025, with a ceiling value of $3,447.42 and an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMQ7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $38,149.93 to supply Kerendia 10 mg tablets (30-count units) with a firm fixed price structure. This competitive award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract does not utilize a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within the scope of AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a broad range of medications and medical supplies to support military and veteran healthcare systems. The Kerendia order reflects the company's role in providing specialty pharmaceuticals across multiple therapeutic domains to the Defense Health Agency and other federal healthcare entities. AmerisourceBergen's competitive contract awards demonstrate its capability to fulfill federal procurement requirements while maintaining the operational efficiency needed to support global military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.1k | 9/11/25 |